ARL15
ADP-ribosylation factor-like protein 15
Also known as: ARFRP2, ARL15_HUMAN, FLJ20051
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NXU5
- Gene
- ARL15
- Ensembl
- ENSG00000185305
- Chromosome
- 5
- Canonical length
- 204 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Microtubules,Cytokinetic bridge,Mitotic spindle,Primary cilium,Basal body
OverviewNCBI Gene
Predicted to enable GTP binding activity and GTPase activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
204 residues, UniProt reviewed canonical sequence.
>Q9NXU5|ARL15
1 MSDLRITEAF LYMDYLCFRA LCCKGPPPAR PEYDLVCIGL TGSGKTSLLS KLCSESPDNV
61 VSTTGFSIKA VPFQNAILNV KELGGADNIR KYWSRYYQGS QGVIFVLDSA SSEDDLEAAR
121 NELHSALQHP QLCTLPFLIL ANHQDKPAAR SVQEIKKYFE LEPLARGKRW ILQPCSLDDM
181 DALKDSFSQL INLLEEKDHE AVRMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARL15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- placenta: 21 nTPM
- kidney: 17 nTPM
- cervix: 16 nTPM
- smooth muscle: 16 nTPM
- endometrium: 15 nTPM
- gallbladder: 13 nTPM
Single-cell type
- renal connecting tubule cells: 3,280 nCPM
- sertoli cells: 2,305 nCPM
- renal collecting duct intercalated cells: 2,220 nCPM
- cytotrophoblasts: 1,519 nCPM
- vascular endothelial cells: 1,394 nCPM
- pituitary stem cells: 1,168 nCPM
Immune cell
- neutrophil: 3.7 nTPM
- T-reg: 2.6 nTPM
- myeloid DC: 2.5 nTPM
- eosinophil: 2.4 nTPM
- classical monocyte: 1.8 nTPM
- intermediate monocyte: 1.5 nTPM
Brain region
- hippocampal formation: 12 nTPM
- cerebral cortex: 12 nTPM
- basal ganglia: 9.8 nTPM
- choroid plexus: 9.6 nTPM
- hypothalamus: 9.2 nTPM
- thalamus: 8.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.2
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.71
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Small GTPase superfamily, ARF/SAR type
- P-loop containing nucleoside triphosphate hydrolase
- ADP-ribosylation factor family
- ADP-ribosylation factor-like protein 15
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARL15 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARL15 as an antibody target. Whether an autoantibody or antibody against ARL15 could matter depends on whether native ARL15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARL15 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARL15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...